The Stanford-linked artificial intelligence technology developer doubled its valuation to $5.1bn in a round led by SoftBank Vision Fund 2.

Asahi Kasei Ventures took part in a $70m round for food waste technology provider Hazel Technologies while Zoll Medical Corporation bought portfolio company Respicardia.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sony has invested a further $200m in the Fortnite and Gears of War developer, at a $28.7bn valuation representing a 66% increase from last August.

The artificial intelligence technology developer doubled its valuation to $5.1bn in a round led by SoftBank Vision Fund 2 and backed by GV and Intel Capital.

Emtek and Microsoft co-led the digital marketplace’s latest round with GIC, investing alongside Standard Chartered’s SC Ventures unit and Naver.

SoftBank Vision Fund 2 led the physical training technology provider’s latest round, which took its total funding to $300m.

Cambrian Biopharma, LG, GlaxoSmithKline, Novo and Takeda all invested in the cell therapy developer to help it close its series C round.

UGA spinout Aruna Bio is working on a treatment for neurodegenerative diseases such as Parkinson’s and multiple sclerosis.

ECBF has supplied an extension to Aphea.Bio’s series B round, which already included Gemma Frisius Fund, Qbic, Vives and V-Bio Ventures.